Connor, Clark & Lunn Investment Management (CC&L)’s MacroGenics MGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.51M	Buy	867,249 +48,429	+6%	+$103K	0.01%	890
2025 Q4	$1.32M	Buy	818,820 +108,212	+15%	+$170K	﹤0.01%	1043
2025 Q3	$1.19M	Buy	710,608 +28,331	+4%	+$45.9K	﹤0.01%	1006
2025 Q2	$826K	Sell	682,277 -133,777	-16%	-$194K	﹤0.01%	1107
2025 Q1	$1.04M	Buy	816,054 +71,152	+10%	+$186K	﹤0.01%	934
2024 Q4	$2.42M	Buy	744,902 +82,988	+13%	+$299K	0.01%	672
2024 Q3	$2.18M	Buy	661,914 +186,858	+39%	+$728K	0.01%	647
2024 Q2	$2.02M	Buy	475,056 +56,774	+14%	+$553K	0.01%	654
2024 Q1	$6.16M	Buy	418,282 +174,086	+71%	+$2.63M	0.03%	385
2023 Q4	$2.35M	Buy	244,196 +104,945	+75%	+$725K	0.01%	629
2023 Q3	$649K	Buy	+139,251	New	+$693K	﹤0.01%	952
2022 Q4	–	Sell	-242,909	Closed	-$840K	–	1350
2022 Q3	$840K	Buy	242,909 +22,114	+10%	+$84.6K	0.01%	694
2022 Q2	$651K	Buy	220,795 +175,342	+386%	+$922K	﹤0.01%	717
2022 Q1	$400K	Buy	45,453 +5,657	+14%	+$62.4K	﹤0.01%	821
2021 Q4	$639K	Buy	39,796 +3,528	+10%	+$66.4K	﹤0.01%	758
2021 Q3	$759K	Buy	+36,268	New	+$874K	﹤0.01%	690
2020 Q2	–	Sell	-65,619	Closed	-$382K	–	1124
2020 Q1	$382K	Buy	65,619 +35,994	+121%	+$327K	﹤0.01%	757
2019 Q4	$322K	Buy	+29,625	New	+$293K	﹤0.01%	750